492 related articles for article (PubMed ID: 21575299)
1. Risk of tuberculosis among contacts of isoniazid-resistant and isoniazid-susceptible cases.
Tuberculosis Research Centre, Indian Council of Medical Research (ICMR), Chennai, India
Int J Tuberc Lung Dis; 2011 Jun; 15(6):782-8. PubMed ID: 21575299
[TBL] [Abstract][Full Text] [Related]
2. Additional risk of developing TB for household members with a TB case at home at intake: a 15-year study.
Radhakrishna S; Frieden TR; Subramani R; Santha T; Narayanan PR;
Int J Tuberc Lung Dis; 2007 Mar; 11(3):282-8. PubMed ID: 17352093
[TBL] [Abstract][Full Text] [Related]
3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
4. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
Kam KM; Yip CW
Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
[TBL] [Abstract][Full Text] [Related]
5. Isoniazid Monoresistance and Rate of Culture Conversion among Patients in the State of Georgia with Confirmed Tuberculosis, 2009-2014.
Salindri AD; Sales RF; DiMiceli L; Schechter MC; Kempker RR; Magee MJ
Ann Am Thorac Soc; 2018 Mar; 15(3):331-340. PubMed ID: 29131662
[TBL] [Abstract][Full Text] [Related]
6. Mini epidemic of isoniazide resistant TB in rural TN: a need for supervised preventive therapy.
Mehta J; Keith R; Al Hasan M; Ryland B; Roy T
Tenn Med; 2009 Aug; 102(8):41-4. PubMed ID: 19691201
[TBL] [Abstract][Full Text] [Related]
7. Infection and disease among household contacts of patients with multidrug-resistant tuberculosis.
Teixeira L; Perkins MD; Johnson JL; Keller R; Palaci M; do Valle Dettoni V; Canedo Rocha LM; Debanne S; Talbot E; Dietze R
Int J Tuberc Lung Dis; 2001 Apr; 5(4):321-8. PubMed ID: 11334250
[TBL] [Abstract][Full Text] [Related]
8. Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes.
Yoshiyama T; Yanai H; Rhiengtong D; Palittapongarnpim P; Nampaisan O; Supawitkul S; Uthaivorawit W; Mori T
Int J Tuberc Lung Dis; 2004 Jan; 8(1):31-8. PubMed ID: 14974743
[TBL] [Abstract][Full Text] [Related]
9. Transmissibility and potential for disease progression of drug resistant
Becerra MC; Huang CC; Lecca L; Bayona J; Contreras C; Calderon R; Yataco R; Galea J; Zhang Z; Atwood S; Cohen T; Mitnick CD; Farmer P; Murray M
BMJ; 2019 Oct; 367():l5894. PubMed ID: 31649017
[TBL] [Abstract][Full Text] [Related]
10. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
[TBL] [Abstract][Full Text] [Related]
11. Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003.
Hoopes AJ; Kammerer JS; Harrington TA; Ijaz K; Armstrong LR
Arch Intern Med; 2008 Oct; 168(18):1984-92. PubMed ID: 18852399
[TBL] [Abstract][Full Text] [Related]
12. A quantitative benefit-risk analysis of isoniazid for treatment of latent tuberculosis infection using incremental benefit framework.
Sadatsafavi M; Marra C; Marra F; Moran O; FitzGerald JM; Lynd L
Value Health; 2013; 16(1):66-75. PubMed ID: 23337217
[TBL] [Abstract][Full Text] [Related]
13. Treatment outcome of new culture positive pulmonary tuberculosis in Norway.
Farah MG; Tverdal A; Steen TW; Heldal E; Brantsaeter AB; Bjune G
BMC Public Health; 2005 Feb; 5():14. PubMed ID: 15698472
[TBL] [Abstract][Full Text] [Related]
14. Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases.
Sneag DB; Schaaf HS; Cotton MF; Zar HJ
Pediatr Infect Dis J; 2007 Dec; 26(12):1142-6. PubMed ID: 18043453
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
16. Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands.
van Soolingen D; de Haas PE; van Doorn HR; Kuijper E; Rinder H; Borgdorff MW
J Infect Dis; 2000 Dec; 182(6):1788-90. PubMed ID: 11069256
[TBL] [Abstract][Full Text] [Related]
17. Extensive transmission of an isoniazid-resistant strain of Mycobacterium tuberculosis in Sweden.
Kan B; Berggren I; Ghebremichael S; Bennet R; Bruchfeld J; Chryssanthou E; Källenius G; Petersson R; Petrini B; Romanus V; Sylvan S; Kalin M
Int J Tuberc Lung Dis; 2008 Feb; 12(2):199-204. PubMed ID: 18230254
[TBL] [Abstract][Full Text] [Related]
18. Contact screening and chemoprophylaxis in India's Revised Tuberculosis Control Programme: a situational analysis.
Banu Rekha VV; Jagarajamma K; Wares F; Chandrasekaran V; Swaminathan S
Int J Tuberc Lung Dis; 2009 Dec; 13(12):1507-12. PubMed ID: 19919768
[TBL] [Abstract][Full Text] [Related]
19. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
Yoshiyama T; Ogata H; Ito K; Aono A; Wada M
Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318
[TBL] [Abstract][Full Text] [Related]
20. Isoniazid (INH) mono-resistance and tuberculosis (TB) treatment success: analysis of European surveillance data, 2002 to 2014.
Karo B; Kohlenberg A; Hollo V; Duarte R; Fiebig L; Jackson S; Kearns C; Ködmön C; Korzeniewska-Kosela M; Papaventsis D; Solovic I; van Soolingen D; van der Werf MJ
Euro Surveill; 2019 Mar; 24(12):. PubMed ID: 30914081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
